How would you treat a 30-year-old woman with systemic lupus erythematous (SLE) and lupus nephritis (LN) class 3 with new ...
Roche's Gazyvaro, a drug that can restore kidney function in people living with lupus nephritis, has been cleared for use by ...
We were joined experts who shared expert insights, practical tips, and personal experiences to empower patients to build ...
NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.
The treatment has been approved for NHS use, offering new hope to the nearly 12,000 people in England living with lupus ...
GSK plc (LSE/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and local non-profit organizations ...
Defense spending bill includes restoration of millions in lupus research funding that had been eliminated last year ...
In patients with active systemic lupus erythematosus unresponsive to conventional hydroxychloroquine-based therapy, adding mepacrine shows improved outcomes with few and mild side effects.
Techno-Science.net on MSN
Lupus: Discovery of markers to identify patients at highest risk
An international team, led by Paul R. Fortin of Université Laval, has just identified three markers that would allow for establishing, right at the time of diagnosis, the risk of a lupus ...
Flow Space on MSN
‘I Thought Feeling This Bad Was Normal': The Overlooked Signs Your Lupus Needs More Attention
There are a few to keep in mind.
Investigators studied expression of type I interferons, key pathogenic drivers in systemic lupus erythematosus and lupus nephritis.
That same sense of purpose now runs through her creative work. A Chicago native who relocated to Kansas City during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results